Superbugs blasted by aerosols

Superbugs blasted by aerosols
Nano-sized antibiotics delivered via aerosol could be the answer to treating superbugs that are resistant to other treatments.

(Medical Xpress)—Blasting superbugs with tiny nano-sized antibiotics delivered via powder aerosol may be a faster, safer and cheaper way of treating respiratory infectious diseases such as pneumonia or cystic fibrosis, claim University of Sydney pharmacy researchers.

Dr Qi (Tony) Zhou, academic researcher in the Faculty of Pharmacy and recipient of this year's 'Peter Doherty - Australian Biomedical Fellowship' awarded by the National Health and Medical Research Council, says respiratory infectious diseases are a major health problem for Australians.

Each year, respiratory tract infections cost Australian taxpayers more than $150 million in direct costs and considerably more in indirect costs due to absenteeism and loss of productivity. Upper and infections account for almost seven million visits to GPs each year in Australia.

With the incidence of respiratory infection on the rise and superbugs now being blamed for the increase, it is imperative that researchers find better treatments to combat these emerging villains, says Dr Zhou.

"At the moment, the most common way of treating is with oral or . Due to antibiotic resistance, treatment using aggressive antibacterial agents is becoming more and more necessary. But these salvage medicines can cause dire side effects for patients such as severe diarrhea, or even irreversible organ damage," Dr Zhou says.

"The antibiotic agent, Colistin for example, is often a last-line offensive against some superbugs. But its can cause neuron or kidney damages in up to 50 percent of patients."

Dr Zhou's team will develop tiny nano-sized antibiotics that will be packaged in inhalers. The team includes world-leader of respiratory drug delivery, Professor Hak-Kim Chan, also from the Faculty of Pharmacy, infectious disease experts at Monash University and a top nanoscience team based at Princeton University, USA.

"These new inhaled nanomedicines will target the antibiotics directly at the respiratory tract. Ultimately they will be easier to carry and operate and have a more rapid drug-action," says Professor Hak-Kim Chan.

"The new inhaled nanoantibiotic therapy will be pivotal in the fight to reduce drug resistance and adverse effects for combating respiratory superbugs."

add to favorites email to friend print save as pdf

Related Stories

Antibiotic use in infants linked to asthma

Jun 11, 2007

New research indicates that children who receive antibiotics before their first birthday are significantly more likely to develop asthma by age 7. The study, published in the June issue of CHEST, the peer-reviewed journal ...

A world without antibiotics?

Apr 07, 2011

Imagine a world without antibiotics. Common infections are life threatening. Pneumonia, urinary tract infections and venereal diseases are incurable. Cancer chemotherapies do not exist. The life expectancy for Canadian men ...

Recommended for you

Ebola kills 31 people in DR Congo: WHO

53 minutes ago

An outbreak of the Ebola virus in the Democratic Republic of Congo has killed 31 people and the epidemic remains contained in a remote northwestern region, UN the World Health Organization (WHO) said Tuesday.

Dengue fever strikes models in Japan

3 hours ago

A worsening outbreak of dengue fever in Japan has claimed its first celebrities—two young models sent on assignment to the Tokyo park believed to be its source.

Japanese researchers develop 30-minute Ebola test

3 hours ago

Japanese researchers said Tuesday they had developed a new method to detect the presence of the Ebola virus in 30 minutes, with technology that could allow doctors to quickly diagnose infection.

Senegal monitors contacts of 1st Ebola patient

15 hours ago

Senegalese authorities on Monday were monitoring everyone who was in contact with a student infected with Ebola who crossed into the country, and who has lost three family members to the disease.

Cerebral palsy may be hereditary

21 hours ago

Cerebral palsy is a neurological developmental disorder which follows an injury to the immature brain before, during or after birth. The resulting condition affects the child's ability to move and in some ...

User comments